|
positive regulation of t cell mediated cytotoxicity
|
GO:0001916 |
15 |
0.177
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.112
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.111
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.092
|
|
|
iron ion import
|
GO:0097286 |
5 |
0.092
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.092
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.090
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.090
|
|
|
cation transport
|
GO:0006812 |
399 |
0.077
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.077
|
|
|
regulation of natural killer cell mediated immunity
|
GO:0002715 |
19 |
0.076
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.070
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.070
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.068
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.062
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.061
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.061
|
|
|
cell killing
|
GO:0001906 |
67 |
0.058
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.057
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.057
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.057
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.056
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.054
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.053
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.053
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.052
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
29 |
0.052
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.052
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.051
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.050
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.049
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.048
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.047
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.046
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.044
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.043
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.041
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.040
|
|
|
activation of meiosis
|
GO:0090427 |
4 |
0.040
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.039
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class ib
|
GO:0002476 |
4 |
0.038
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.038
|
|
|
renal system process
|
GO:0003014 |
48 |
0.037
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.035
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.035
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.035
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.035
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.034
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.034
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.033
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.033
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.033
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.033
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.032
|
|
|
regulation of t cell mediated cytotoxicity
|
GO:0001914 |
18 |
0.032
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.032
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.031
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.031
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.031
|
|
|
negative regulation of monocyte extravasation
|
GO:2000438 |
1 |
0.031
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.030
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.030
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.029
|
|
|
prostate gland morphogenetic growth
|
GO:0060737 |
4 |
0.029
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
29 |
0.029
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.029
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.029
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.028
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.028
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.028
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.028
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.028
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.027
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.027
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.027
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.027
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.027
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.027
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.026
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.026
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.026
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.026
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.026
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.026
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.025
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.025
|
|
|
ear development
|
GO:0043583 |
200 |
0.025
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.025
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.025
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.025
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.025
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.025
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.025
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
4 |
0.025
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.024
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.024
|
|
|
polyol metabolic process
|
GO:0019751 |
26 |
0.024
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.024
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.024
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.024
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.024
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.024
|
|
|
inorganic cation import into cell
|
GO:0098659 |
4 |
0.024
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.023
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.023
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.023
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.023
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.023
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.023
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.023
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.023
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.023
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.022
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.022
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.022
|
|
|
skin development
|
GO:0043588 |
220 |
0.022
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.021
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.021
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.021
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class i
|
GO:0019885 |
3 |
0.021
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.021
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.020
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.020
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.020
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.020
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.020
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.020
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.020
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.020
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.020
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.020
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.020
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.020
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.020
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.020
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.020
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.020
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.019
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.019
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.019
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.019
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.019
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.019
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.018
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.018
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.018
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.018
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.018
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.018
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.018
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.018
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.018
|
|
|
histamine transport
|
GO:0051608 |
2 |
0.018
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.018
|
|
|
iron ion import into cell
|
GO:0097459 |
4 |
0.018
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.018
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.017
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.017
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.017
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.017
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.017
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.017
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.017
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.017
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.017
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.017
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.017
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class i via er pathway
|
GO:0002484 |
3 |
0.016
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.016
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.016
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.016
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.016
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.016
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.016
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.016
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.016
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.016
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.016
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.016
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.016
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.016
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.015
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.015
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.015
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.015
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.015
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.015
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.015
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.015
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.015
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.015
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.015
|
|
|
positive regulation of natural killer cell mediated immunity
|
GO:0002717 |
16 |
0.015
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.015
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.015
|
|
|
regulation of monocyte extravasation
|
GO:2000437 |
2 |
0.015
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.015
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.015
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.015
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.014
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.014
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.014
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.014
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.014
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.014
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.014
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.014
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.014
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
3 |
0.014
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.014
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.014
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.014
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.014
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.014
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.014
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.014
|
|
|
regulation of t cell mediated immunity
|
GO:0002709 |
34 |
0.014
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.014
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.014
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.014
|
|
|
action potential
|
GO:0001508 |
78 |
0.014
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.014
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.014
|
|
|
viral process
|
GO:0016032 |
41 |
0.014
|
|
|
visual perception
|
GO:0007601 |
52 |
0.014
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class ib via er pathway
|
GO:0002488 |
2 |
0.014
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.014
|
|
|
membrane depolarization during sa node cell action potential
|
GO:0086046 |
2 |
0.013
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.013
|
|
|
regulation of serotonin secretion
|
GO:0014062 |
3 |
0.013
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.013
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.013
|
|
|
positive regulation of natural killer cell mediated cytotoxicity
|
GO:0045954 |
16 |
0.013
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.013
|
|
|
fertilization
|
GO:0009566 |
127 |
0.013
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.013
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.013
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.013
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.013
|
|
|
cellular response to epidermal growth factor stimulus
|
GO:0071364 |
4 |
0.013
|
|
|
response to pain
|
GO:0048265 |
26 |
0.013
|
|
|
antigen processing and presentation of endogenous peptide antigen
|
GO:0002483 |
6 |
0.012
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class ib
|
GO:0002477 |
3 |
0.012
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.012
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.012
|
|
|
antigen processing and presentation via mhc class ib
|
GO:0002475 |
8 |
0.012
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.012
|
|
|
regulation of store operated calcium channel activity
|
GO:1901339 |
1 |
0.012
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.012
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.012
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.012
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.012
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.012
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.012
|
|
|
protein processing
|
GO:0016485 |
163 |
0.012
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.012
|
|
|
b 1 b cell differentiation
|
GO:0001923 |
3 |
0.012
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.012
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.012
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.012
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.012
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.012
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.012
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.012
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.012
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.011
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.011
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.011
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.011
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.011
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.011
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.011
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.011
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.011
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.011
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.011
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.011
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.011
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.011
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.011
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.011
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.011
|
|
|
sodium ion homeostasis
|
GO:0055078 |
7 |
0.011
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.011
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.011
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.011
|
|
|
norepinephrine epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001994 |
3 |
0.011
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.011
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.011
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.011
|
|
|
inclusion body assembly
|
GO:0070841 |
3 |
0.011
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.011
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.011
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.011
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.011
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.011
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.011
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.011
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.011
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.011
|
|
|
monocyte extravasation
|
GO:0035696 |
2 |
0.011
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.011
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.010
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.010
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.010
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.010
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.010
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.010
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.010
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.010
|
|
|
alpha beta t cell activation involved in immune response
|
GO:0002287 |
31 |
0.010
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.010
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.010
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.010
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.010
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.010
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.010
|
|
|
serotonin receptor signaling pathway
|
GO:0007210 |
8 |
0.010
|
|
|
organ growth
|
GO:0035265 |
117 |
0.010
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.010
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.010
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.010
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.010
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.010
|
|
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:1901145 |
4 |
0.010
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.010
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.010
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.010
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.010
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.010
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.010
|
|